Ornidazol (When ATH J01XD03)

When ATH:
J01XD03

Pharmacological action.
Protivoprotozoynymi, Antibacterial.

Application.

Trichomoniasis (urinary tract infections, caused Trichomonas vaginalis), ameʙiaz (intestinal infections, caused Entamoeba histolytica, incl. amebnaya dysentery, extra-intestinal amebiasis, incl. amebic liver abscess), giardiasis; prevention of infections, caused by anaerobic bacteria, in operations on the colon and Gynecology.

Contraindications.

Hypersensitivity, CNS disorders, pregnancy, lactation.

Side effects.

Dizziness, headache, disturbance of consciousness, tremor, rigidity, discoordination movements, convulsions, sensory or mixed peripheral neuropathy, dyspeptic disorders.

Cooperation.

It enhances the effect of coumarin anticoagulants, prolong the action of muscle relaxant vecuronium bromide. Unlike other imidazole derivatives (metronidazol) compatible with alcohol (It does not inhibit atsetaldegiddegidrogenazu).

Overdose.

Symptoms: epileptiform convulsions, depression, peripheral neuritis.

Treatment: symptomatic.

Dosing and Administration.

Inside, after meal. If trichomoniasis: by 0,5 g in the morning and evening for 5 days; children once - 25 mg / kg body weight per day.

In amoebic dysentery: a course of treatment 3 day, adults and children weighing more than 35 kg - 1,5 g once, in the evening; adults weighing over 60 kg - for 1,5 g morning and evening, children weighing up to 35 kg - 40 mg / kg per day, single.

In all forms of amebiasis: for 5-10 days in adults and children weighing more than 35 kg - for 0,5 g morning and evening; children weighing up to 35 kg - 25 mg / kg once.

When giardiasis: adults and children weighing more than 35 kg - 1,5 g once, in the evening, children weighing up 35 kg - 40 mg / kg once; treatment 1-2 days.

When infections, caused by anaerobic bacteria: 0,5 g every 12 no.